Breast cancer screening is a key part of preventive health care. So, it’s puzzling why some insurance plans don’t fully cover the necessary imaging for patients.
This has frustrated patients for years, prompting Congress to respond. A bill known as the Access to Breast Cancer Diagnosis (ABCD) Act has been reintroduced, aiming to require federally regulated health plans to cover both diagnostic and supplementary breast imaging.
For many individuals, including women and men, the reality is far more complex than just accessing screenings. It’s unfortunate, really—many patients face financial hurdles that complicate their care.
Take the example of a patient undergoing routine breast cancer screening. If the results are unclear, they often need further imaging, like diagnostic mammograms or ultrasounds, to guide decisions about biopsies. In the current situation, this can lead to substantial out-of-pocket expenses.
Now, consider another scenario. A patient with a family history of breast cancer or certain genetic predispositions might be advised to have additional imaging. But again, the costs of these necessary tests can create a heavy financial burden that’s hard to manage.
In the U.S., it’s alarming to note that 116 women are expected to die of breast cancer daily this year. Early detection is proven to be lifesaving. So it raises questions: why are patients still struggling to obtain timely imaging and answers necessary for treatment?
The crux of the problem lies with insurance providers, which are obliged to cover annual mammograms but not the diagnostic or supplementary imaging that many patients require without imposing costs on them. This inconsistency leads patients to face thousands of dollars in out-of-pocket fees for essential and preventative care.
Research indicates that those burdened with high costs are less likely to follow through with needed imaging. When patients feel they must postpone diagnosis and treatment, they’re taking significant risks. Without timely imaging and diagnosis, breast cancer could advance, making treatment far more challenging and expensive.
The ABCD Act holds promise; by mandating federally regulated health plans to cover diagnostic and supplementary imaging without costs to patients, it could lead to quicker diagnoses for many.
This would also help those on high-deductible plans—typically younger, healthier individuals who might not anticipate needing extensive care. If they require additional imaging, they often face significantly higher deductibles compared to those with traditional plans.
What’s more, the ABCD Act could reduce disparities in care. Evidence shows that Black patients with breast cancer who are insured under federally regulated plans often receive late diagnoses, resulting in higher mortality rates. Similarly, Hispanic patients living in lower-income households are more prone to skip essential follow-up appointments, as highlighted by recent data.
The bill aims to eliminate these financial barriers, ensuring patients can more readily access critical imaging. Importantly, it does so without negatively impacting costs or premiums. So far, similar legislation that removes patient cost-sharing for diagnostic and supplementary imaging has been enacted in 29 states, with studies revealing minimal effects on insurance premiums.
Affordable access to essential imaging is vital for improving breast cancer outcomes in the U.S. Waiting for treatment can lead to more severe and costly interventions for patients.
Smart policies can truly change and save lives. The need for action is urgent, as financial concerns should never stand in the way of caring for breast cancer patients.
